She signed the forms, took the injections, and trusted the doctor who called it "mild discomfort."
Then she woke up from retrieval feeling like she'd been punched from the inside.
This article is about what the industry didn't tell her, and what it may not be telling you.
The Phrase "Mild Discomfort" Is Doing a Lot of Heavy Lifting
Clinics use that phrase like a universal disclaimer.
"Mild discomfort" describes everything from a stubbed toe to days of severe abdominal swelling.
Donors repeatedly describe feeling "bruised inside" for days post-retrieval.
That's not mild anything.
The problem isn't just semantics.
It's that the clinical language was never calibrated to actual donor experience.
It was calibrated to keep recruitment moving.
What Healthy Women Are Doing Instead of Accepting "Mild Discomfort" as an Answer
The Studies That Were Supposed to Protect You Weren't About You
Here's the quiet scandal inside the bigger scandal.
The safety assurances given to egg donors were largely not based on donor-specific longitudinal research.
They were borrowed from IVF patient data, which studies recipients, not donors.
Donors and recipients are biologically different populations with different risk profiles.
One nurse who donated professionally admitted she asked only 3 of her 10 prepared questions.
She was "too scared" to ask the rest.
If a nurse felt silenced in that room, consider what a 22-year-old student facing debt felt.
According to the American Society for Reproductive Medicine, long-term donor outcome data remains significantly limited.
That gap isn't accidental.
It's expensive to follow donors for decades, and the industry bears the cost without obvious financial benefit.
Before You Donate, See the Screening and Support Standards You Should Expect
The Informed Consent Form That Wasn't Fully Informing Anyone
Consent forms are long, clinical, and written in a register that rewards medical fluency.
Most first-time donors are in their early twenties, carrying student debt, and reading them alone.
The compensation figure, often $10,000 to $20,000 per cycle, is not subtle motivation.
Critics argue that offering large sums to financially stressed young women compromises genuinely free consent.
That's not a fringe position.
The ethics of targeting campus advertising at high-debt demographics has been openly debated in reproductive medicine journals.
Signing a form you didn't fully understand doesn't make you naive.
It makes you human, inside a system that wasn't designed to slow down for questions.
What Women in Their Twenties Are Using To Make an Informed Donation Decision
What Happens After the Retrieval Is Almost Entirely Up to You
Post-retrieval support from clinics tends to evaporate quickly.
Once the eggs are collected, the clinic's operational interest in the donor largely ends.
Many donors turn to YouTube and TikTok to understand their own recovery.
That's not empowerment.
That's a gap in duty of care filled by strangers on the internet.
Donors with very high egg yields, sometimes exceeding 36 eggs per cycle, later questioned whether they were pushed too far.
Severe ovarian hyperstimulation syndrome (OHSS) can require hospitalization.
Yet that outcome often feels abstract in consent materials until it isn't.
Find a Program That Keeps Supporting You After the Retrieval Is Done
The Anonymity Agreement You Signed Is Now a Historical Document
Consumer DNA testing changed everything, permanently, and without asking donors for permission.
Donor-conceived individuals are finding genetic relatives through services like 23andMe every single day.
An anonymity clause signed in 2007 has no mechanism to stop a DNA kit bought in 2024.
Some donors welcome contact.
Others were categorically unprepared for it.
Neither reaction was wrong.
But the lack of preparation was entirely preventable, and largely ignored by the industry.
Are You Prepared for What Happens When a DNA Test Finds Your Genetic Relatives?
What Reputable Programs Actually Owe Donors
Not every clinic operates the same way.
Programs that lead with transparency, comprehensive screening, and clear communication about risks represent a different standard.
MyEggBank, for example, provides full medical and genetic screening, structured support, and compensation from $10,000 to $20,000 per cycle.
Donors can earn up to $90,000 across six cycles.
The difference between a good program and a problematic one often comes down to whether donor welfare is built into the process, not bolted on afterward.
Knowing what questions to ask, and which programs will actually answer them, is where informed decision-making begins.
The One Standard That Separates a Program Worth Trusting From One That Isn't
The Conversation the Industry Still Hasn't Had
Large-scale, long-term research specifically tracking donor health outcomes still does not exist at the scale it should.
The fertility industry has had decades to commission it.
The 95% no-regret statistic cited most often comes from small, older samples with significant methodological limitations.
Mood swings, emotional volatility, and complex feelings about genetic offspring are mentioned in passing, not foregrounded.
Donors deserve the same depth of follow-up that recipients receive, without having to fight for it.
That's not an unreasonable ask.
It's the minimum standard for a medical procedure performed on a healthy body for someone else's benefit.
Why Thousands of Healthy Women Are Choosing Programs That Track Their Outcomes